Book Lynch Syndrome Screening in Saudi Arabia | Lahalak Medical Platform

An advanced genetic screening to detect mutations linked to colorectal and endometrial cancers, enabling early detection and personalized preventive strategies for you and your family's long-term health.

Scientific name: Lynch Syndrome Genetic Screening (MLH1, MSH2, MSH6, PMS2, EPCAM)

A specialized genetic test analyzing MLH1, MSH2, MSH6, PMS2, and EPCAM genes to identify Lynch Syndrome predisposition and associated hereditary cancer risks for proactive medical management.

Lynch Syndrome Genetic Screening (MLH1, MSH2, MSH6, PMS2, EPCAM) - Protect Your Family from Hereditary Cancers
Service type Genetic Testing
Duration 15-20 minutes
Fasting Fasting is not required

Included Services

  • Blood or saliva sample collection
  • Sequencing of the five core genes
  • Detailed medical result report

Medical Service Information

Purpose of the Screening

  • Identify risks for colorectal and endometrial cancers.
  • Evaluate genetic predisposition for ovarian and stomach cancers.
  • Provide vital information for family members' health.
  • Establish a personalized early-surveillance medical plan.

Genes Analyzed

  • MLH1 and MSH2 (Primary Lynch-associated genes).
  • MSH6 and PMS2 (Mismatch repair genes).
  • EPCAM gene deletions.

Who Should Consider This Test?

  • Individuals diagnosed with colon cancer before age 50.
  • People with a strong family history of Lynch-related cancers.
  • Anyone with a relative known to have a germline mutation in MMR genes.

Conditions & Notices

  • Family medical history is recommended
  • No dietary preparations required

Medical services you might also like